IGF2 and ovarian carcinoma: A single microarray study showed that IGFBP-6 mRNA levels were lower in ovarian cancer tissue compared with non-cancerous tissue (18); this may reflect derepression of IGF-II action by decreased IGFBP-6, but levels were not confirmed in an independent assay.